GSK to 'drop patents in poor countries'

GlaxoSmithKline to ‘drop patents in poor countries for better drug access’

  • 31 March 2016
  • From the section Health

GSKImage copyright
Reuters

Pharmaceutical firm GlaxoSmithKline has said it wants to make it easier for manufacturers in the world’s poorest countries to copy its medicines.

The British company said it would not file patents in these countries.

Chief executive Sir Andrew Witty said he wanted to take a “graduated” approach to the company’s “intellectual property” based on the wealth of nations around the globe.

Experts have described the plans as “brave and positive”.

'Major gaps' in end-of-life care

Around the clock care for dying ‘not good enough’

By Smitha Mundasad
Health reporter
  • 31 March 2016
  • From the section Health

Palliative care - file pictureImage copyright
Amelie-Benoist / BSIP/SPL

A national review of end-of-life care has found most hospitals are failing to provide face-to-face palliative care specialists around the clock.

The review shows only 16 of 142 hospital sites in England offer specialists on site 24/7.

NHS experts acknowledge steady improvements in the last two years, but warn there is still work to do.

It’s the first review since the controversial Liverpool Care Pathway was scrapped.

Collisions with other cyclists are major cause of race injuries

Australia's team race during the 4000m team pursuit qualifying at the 2014 Commonwealth Games in the Chris Hoy velodrome in Glasgow, Scotland, July 24, 2014. REUTERS/Andrew Winning
Australia’s team race during the 4000m team pursuit qualifying at the 2014 Commonwealth Games in the Chris Hoy velodrome in Glasgow, Scotland, July 24, 2014.

Reuters/Andrew Winning


(Reuters Health) – Based on data from northern Belgium, almost one in six non-professional cyclists suffers an accident during a race and colliding with other riders is a major cause.

“Although the number of accidents is quite high, luckily most lesions are minor,” said senior author Dr. Alexander Van Tongel of Ghent University Hospital.

Longer night fasting tied to reduced breast cancer recurrence


(Reuters Health) – For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests.

Women in the study were more likely to have their breast cancer come back if they fasted overnight for less than 13 hours, researchers found.

While prolonged fasting is likely harmless, the study’s lead author cautions that more research is needed before women start fasting to prevent their cancer from coming back.

The Marketplace Risk Adjustment Program: Promoting Access, Quality, and Choice for Consumers

The Marketplace Risk Adjustment Program: Promoting Access, Quality, and Choice for Consumers

March 30

By Kevin Counihan, CEO of the Health Insurance Marketplaces
Dr. Patrick Conway, CMS Acting Principal Deputy Administrator

This week, CMS brings together health care stakeholders and experts to discuss an esoteric sounding, yet important, topic: the individual and small group market risk adjustment programs created by the Affordable Care Act (ACA).  Risk adjustment is critical to making the ACA’s better-known market reforms work well for insurers and consumers. By reducing incentives for issuers to try to design products that attract a healthy risk pool, risk adjustment lets issuers compete on quality, price, and products that meet the needs of all consumers, protecting consumers’ access to a range of robust options.

The Marketplace Risk Adjustment Program: Promoting Access, Quality, and Choice for Consumers

The Marketplace Risk Adjustment Program: Promoting Access, Quality, and Choice for Consumers

March 30

By Kevin Counihan, CEO of the Health Insurance Marketplaces
Dr. Patrick Conway, CMS Acting Principal Deputy Administrator

This week, CMS brings together health care stakeholders and experts to discuss an esoteric sounding, yet important, topic: the individual and small group market risk adjustment programs created by the Affordable Care Act (ACA).  Risk adjustment is critical to making the ACA’s better-known market reforms work well for insurers and consumers. By reducing incentives for issuers to try to design products that attract a healthy risk pool, risk adjustment lets issuers compete on quality, price, and products that meet the needs of all consumers, protecting consumers’ access to a range of robust options.

CMS Invites Quality Innovation Network-Quality Improvement Organizations to Submit Special Innovation Projects to Expand Their Reach in Improving Care Delivery

CMS Invites Quality Innovation Network-Quality Improvement Organizations to Submit Special Innovation Projects to Expand Their Reach in Improving Care Delivery

March 30

By: Patrick Conway, MD, MSc
Acting Principal Deputy Administrator
Deputy Administrator for Innovation and Quality
CMS Chief Medical Officer

Kate Goodrich, MD MHS
Director
Center for Clinical Standards and Quality

Jean Moody-Williams, RN, MPP
Deputy Director
Center for Clinical Standards and Quality

Dennis Wagner, MPA
Director, Quality Improvement and Innovation Group
Center for Clinical Standards and Quality

CMS Invites Quality Innovation Network-Quality Improvement Organizations to Submit Special Innovation Projects to Expand Their Reach in Improving Care Delivery

CMS Invites Quality Innovation Network-Quality Improvement Organizations to Submit Special Innovation Projects to Expand Their Reach in Improving Care Delivery

March 30

By: Patrick Conway, MD, MSc
Acting Principal Deputy Administrator
Deputy Administrator for Innovation and Quality
CMS Chief Medical Officer

Kate Goodrich, MD MHS
Director
Center for Clinical Standards and Quality

Jean Moody-Williams, RN, MPP
Deputy Director
Center for Clinical Standards and Quality

Dennis Wagner, MPA
Director, Quality Improvement and Innovation Group
Center for Clinical Standards and Quality